Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06295835 · ClinicalTrials.gov registry record · NA
Method Comparison Study for Measuring Potassium (K) and Ionized Calcium (iCa) in Blood
A NA study of Potassium (K) & Ionized Calcium (iCa) in Capillary Whole Blood, sponsored by Abbott Point of Care.
- Completed
- Registry status
- NA
- Development phase
- 232
- Enrollment target
- 4
- Study locations
NCT06295835: Completed NA study of Potassium (K) & Ionized Calcium (iCa) in Capillary Whole Blood, sponsored by Abbott Point of Care.
NCT06295835 is a NA study of Potassium (K) & Ionized Calcium (iCa) in Capillary Whole Blood that has completed, run by Abbott Point of Care. The registered enrollment target is 232 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06295835, a NA study of Potassium (K) & Ionized Calcium (iCa) in Capillary Whole Blood, has completed, sponsored by Abbott Point of Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 232 participants
- Enrollment target
- 4
- Study locations
Study Summary
Method comparison study for Potassium (K) and ionized calcium (iCa).
Primary Outcome
Compare the performance of the Potassium (K) test using the IUO i-STAT CG8+ Cartridge on the i-STAT 1 Analyzer to the performance of the K test on a comparator device.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Fingerstick blood draw
Study Locations (4)
Maryland
- University of Maryland (UMD) - Baltimore
Pennsylvania
- Penn State University Hershey Medical Center (Hershey) - Hershey
Washington
- Eastside Research Associates (ERA) - Redmond
Ontario
- Abbott Point of Care (APOC) - Ottawa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 232 participants |
| Start Date | 2024-05-31 |
| Est. Completion | 2025-01-29 |
| Phase | NA |
What the finished NCT06295835 record still lists
NCT06295835 is an interventional study that assigns participants to a tested intervention. The registered 232 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Potassium (K) & Ionized Calcium (iCa) in Capillary Whole Blood appearing as the primary indexed condition, and to 1 intervention - of which Fingerstick blood draw is the first listed.
NCT06295835 reports a single indexed study location in Maryland, Pennsylvania, Washington.
Frequently Asked Questions
What is clinical trial NCT06295835 about?
NCT06295835 is a clinical study titled "Method Comparison Study for Measuring Potassium (K) and Ionized Calcium (iCa) in Blood". Method comparison study for Potassium (K) and ionized calcium (iCa).
What is the current status of trial NCT06295835?
This trial is currently completed. It is a NA study. The enrollment target is 232 participants. The study started on 2024-05-31. Estimated completion is 2025-01-29.
What conditions does trial NCT06295835 study?
This clinical trial studies the following conditions: Potassium (K) & Ionized Calcium (iCa) in Capillary Whole Blood.
What interventions are being tested in trial NCT06295835?
The interventions under investigation include: Fingerstick blood draw (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06295835?
This trial is sponsored by Abbott Point of Care, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06295835 being conducted?
This trial has 4 study locations across Maryland, Pennsylvania, Washington, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06295835's enrollment target sits among peer trials
232 463rd of 2000 higher than 1,536 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01356290 · 232 participants · Phase 2
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
- NCT04753359 · 232 participants · NA
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
- NCT04770870 · 232 participants · NA
Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System
- NCT05948943 · 232 participants · Phase 2
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI